Skip to main content

Table 4 Comparison of the dose differences between the optimized strategy and nonmagnetic field plan

From: Influence and optimization strategy of the magnetic field in 1.5 T MR-linac liver stereotactic radiotherapy

 

Plan0 T

Plan30

Plan60

Plan80

Planangle

I quadrant

     

 HI

1.05 ± 0.01

1.08 ± 0.01 (0.027)

1.05 ± 0.01 (0.366)

1.05 ± 0.01 (0.527)

1.07 ± 0.03 (0.007)

 Dmin(%)

100.96 ± 22.78

99.54 ± 35.2 (0.116)

98.34 ± 23.41 (0.006)

98.08 ± 22.4 (0.006)

97.82 ± 24.05 (0.013)

 Dmax (%)

119.06 ± 28.52

128.8 ± 40.96 (0.028)

120.11 ± 30.19 (0.087)

120.01 ± 29.65 (0.019)

121.04 ± 29.23 (0.019)

II quadrant

     

 HI

0.99 ± 0.24

1.08 ± 0.03 (0.002)

1.06 ± 0.02 (0.005)

1.05 ± 0.02 (0.142)

1.07 ± 0.02 (0.001)

 Dmin (%)

89.96 ± 21.23

86.6 ± 6.28 (0.002)

89.25 ± 5.29 (< 0.001)

90.01 ± 5.24 (0.001)

89.19 ± 5.61 (< 0.001)

 Dmax (%)

104.05 ± 24.86

111.35 ± 2.25 (0.002)

110.32 ± 1.79 (0.043)

110.1 ± 1.55 (0.184)

110.38 ± 1.36 (0.091)

III quadrant

     

 HI

0.98 ± 0.25

1.07 ± 0.02 (0.041)

1.05 ± 0.01 (0.837)

1.05 ± 0.01 (0.313)

1.09 ± 0.13 (0.006)

 Dmax (%)

102.31 ± 26

110.66 ± 1.92 (0.028)

109.48 ± 1.89 (0.002)

109.65 ± 1.99 (0.002)

109.82 ± 1.88 (0.031)

 L-P V30 (%)

5.81 ± 3.22

10.77 ± 8.24 (0.080)

10.65 ± 9.6 (0.110)

7.82 ± 4.18 (0.753)

9.54 ± 6.98 (0.499)

IV quadrant

     

 HI

1.05 ± 0.01

1.08 ± 0.01 (0.007)

1.06 ± 0.01 (0.132)

1.06 ± 0.01 (0.180)

1.06 ± 0.01 (0.002)

 Dmin (%)

93.04 ± 4.86

85.34 ± 10.26 (0.008)

90.17 ± 6.65 (0.060)

92.09 ± 3.78 (0.091)

90.31 ± 5.62 (0.015)